Patents by Inventor Vanessa BUATOIS

Vanessa BUATOIS has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • BISPECIFIC ANTIBODIES AGAINST CEACAM5 AND CD47
    Publication number: 20240101705
    Abstract: The present invention relates to bispecific antibodies which bind to human carcinoembryonic antigen CEACAM5 and human CD47. In addition, the present invention relates to polynucleotides encoding such bispecific antibodies and vectors and host cells comprising such polynucleotides. The invention further relates to methods for selecting and producing such antibodies and to methods of using such antibodies in the treatment of diseases. The invention also relates to the therapeutic use of the bispecific antibodies in monotherapy and in combination therapy.
    Type: Application
    Filed: July 31, 2023
    Publication date: March 28, 2024
    Inventors: Vanessa BUATOIS, Dirk HOSE, Anja SECKINGER
  • BISPECIFIC ANTIBODIES AGAINST CEACAM5 AND CD47
    Publication number: 20240084001
    Abstract: The invention provides bispecific antibodies binding to human carcinoembryonic antigen CEACAM5 and human CD47, polynucleotides encoding such bispecific antibodies and vectors and host cells comprising such polynucleotides. The invention further provides methods for selecting and producing such antibodies and methods of using such antibodies in the treatment of diseases in monotherapy as well in combination.
    Type: Application
    Filed: December 8, 2022
    Publication date: March 14, 2024
    Applicant: LamKap Bio beta Ltd.
    Inventors: Vanessa BUATOIS, Sara MAJOCCHI, Klaus STREIN
  • Bispecific antibodies against CEACAM5 and CD47
    Patent number: 11753481
    Abstract: The present invention relates to bispecific antibodies which bind to human carcinoembryonic antigen CEACAM5 and human CD47. In addition, the present invention relates to polynucleotides encoding such bispecific antibodies and vectors and host cells comprising such polynucleotides. The invention further relates to methods for selecting and producing such antibodies and to methods of using such antibodies in the treatment of diseases. The invention also relates to the therapeutic use of the bispecific antibodies in monotherapy and in combination therapy.
    Type: Grant
    Filed: December 17, 2021
    Date of Patent: September 12, 2023
    Assignee: LAMKAP BIO BETA LTD
    Inventors: Vanessa Buatois, Dirk Hose, Anja Seckinger
  • Bispecific antibodies against CEACAM5 and CD47
    Patent number: 11555071
    Abstract: The invention provides bispecific antibodies binding to human carcinoembryonic antigen CEACAM5 and human CD47, polynucleotides encoding such bispecific antibodies and vectors and host cells comprising such polynucleotides. The invention further provides methods for selecting and producing such antibodies and methods of using such antibodies in the treatment of diseases in monotherapy as well in combination.
    Type: Grant
    Filed: May 31, 2019
    Date of Patent: January 17, 2023
    Assignee: LamKap Bio beta Ltd.
    Inventors: Vanessa Buatois, Stefano Majocchi, Klaus Strein
  • BISPECIFIC ANTIBODIES AGAINST CEACAM5 AND CD47
    Publication number: 20220195067
    Abstract: The present invention relates to bispecific antibodies which bind to human carcinoembryonic antigen CEACAM5 and human CD47. In addition, the present invention relates to polynucleotides encoding such bispecific antibodies and vectors and host cells comprising such polynucleotides. The invention further relates to methods for selecting and producing such antibodies and to methods of using such antibodies in the treatment of diseases. The invention also relates to the therapeutic use of the bispecific antibodies in monotherapy and in combination therapy.
    Type: Application
    Filed: December 17, 2021
    Publication date: June 23, 2022
    Inventors: Vanessa BUATOIS, Dirk HOSE, Anja SECKINGER
  • BISPECIFIC ANTIBODIES AGAINST CEACAM5 AND CD47
    Publication number: 20210221908
    Abstract: The invention provides bispecific antibodies binding to human carcinoembryonic antigen CEACAM5 and human CD47, polynucleotides encoding such bispecific antibodies and vectors and host cells comprising such polynucleotides. The invention further provides methods for selecting and producing such antibodies and methods of using such antibodies in the treatment of diseases inmonotherapy as well in combination.
    Type: Application
    Filed: May 31, 2019
    Publication date: July 22, 2021
    Inventors: Vanessa BUATOIS, Sara MAJOCCHI, Klaus STREIN
  • BISPECIFIC ANTIBODIES AGAINST CEACAM5 AND CD47
    Publication number: 20200123252
    Abstract: The invention provides bispecific antibodies binding to human carcinoembryonic antigen CEACAM5 and human CD47, polynucleotides encoding such bispecific antibodies and vectors and host cells comprising such polynucleotides. The invention further provides methods for selecting and producing such antibodies and methods of using such antibodies in the treatment of diseases in monotherapy as well in combination.
    Type: Application
    Filed: May 31, 2019
    Publication date: April 23, 2020
    Applicant: LamKap Bio beta Ltd.
    Inventors: Vanessa BUATOIS, Stefano MAJOCCHI, Klaus STREIN